Literature DB >> 10603624

Compliance in asthma.

G M Cochrane1, R Horne, P Chanez.   

Abstract

Low rates of compliance with medication pose a major challenge to the effective management of most chronic diseases, including asthma. The high medical and social costs of non-compliance, and the apparent lack of effective methods for dealing with it, has stimulated renewed interest in this complex issue. Two broad categories of non-compliance have been identified, namely unintentional (or 'accidental') and intentional (or 'deliberate'). Unintentional non-compliance may result from poor doctor-patient communication or a lack of ability to follow advice. Intentional non-compliance occurs when the patient knows what is required but decides not to follow this to some degree. Healthcare professionals need to be aware of the various issues affecting compliance in all patients. The reasons for non-compliance are many and varied, and include factors such as complexity of the treatment regimen, administration route, patient beliefs about therapy and other psychological factors. Improvement in patient compliance with therapy will require better doctor-patient communication, improved patient education, the tailoring of therapy to the individual and possible novel strategies such as offering feedback to the patients on their level of compliance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603624     DOI: 10.1016/s0954-6111(99)90260-3

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  40 in total

1.  Sharing prescription medicines: results of a survey of community pharmacy clients in Auckland, New Zealand.

Authors:  Alexandra Gascoyne; Kebede Beyene; Joanna Stewart; Trudi Aspden; Janie Sheridan
Journal:  Int J Clin Pharm       Date:  2014-11-02

2.  Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.

Authors:  S Suissa; P Ernst; A Kezouh
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 3.  Asthma education for school staff.

Authors:  Kayleigh M Kew; Robin Carr; Tim Donovan; Morris Gordon
Journal:  Cochrane Database Syst Rev       Date:  2017-04-12

Review 4.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

5.  Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.

Authors:  N Kheir; L Emmerton; J Shaw
Journal:  J Sci Res Med Sci       Date:  2001-10

6.  The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers.

Authors:  Marios Kyriazis
Journal:  Rejuvenation Res       Date:  2014-08       Impact factor: 4.663

7.  Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis.

Authors:  John Denyer; Alex Black; Kurt Nikander; Tony Dyche; Ivan Prince
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

Review 8.  Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.

Authors:  A Markham; J C Adkins
Journal:  Pharmacoeconomics       Date:  2000-12       Impact factor: 4.981

9.  Parental attitudes towards the management of asthma in ethnic minorities.

Authors:  Nigel C Smeeton; Roberto J Rona; Jane Gregory; Patrick White; Myfanwy Morgan
Journal:  Arch Dis Child       Date:  2007-02-06       Impact factor: 3.791

10.  Fluticasone propionate in asthma: a long term dose comparison study.

Authors:  E Verona; D Petrov; E Cserhati; J Hofman; N Geppe; H Medley; S Hughes
Journal:  Arch Dis Child       Date:  2003-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.